LVM Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-49,306	Closed	-$3.76M	–	148
2023 Q1	$3.76M	Sell	49,306 -2,350	-5%	-$195K	0.52%	45
2022 Q4	$4.29M	Sell	51,656 -7,132	-12%	-$577K	0.62%	45
2022 Q3	$4.66M	Sell	58,788 -6,290	-10%	-$530K	0.71%	41
2022 Q2	$4.83M	Sell	65,078 -12,000	-16%	-$901K	0.7%	41
2022 Q1	$6.93M	Buy	77,078 +5,447	+8%	+$503K	0.92%	37
2021 Q4	$8.02M	Buy	71,631 +1,271	+2%	+$153K	1.07%	34
2021 Q3	$8.85M	Buy	70,360 +1,921	+3%	+$247K	1.33%	28
2021 Q2	$9.27M	Buy	68,439 +2,325	+4%	+$306K	1.41%	27
2021 Q1	$8.97M	Sell	66,114 -752	-1%	-$113K	1.45%	27
2020 Q4	$9.41M	Sell	66,866 -710	-1%	-$90.9K	1.59%	25
2020 Q3	$7.53M	Buy	67,576 +6,180	+10%	+$693K	1.46%	26
2020 Q2	$6.87M	Buy	+61,396	New	+$6.05M	1.41%	27